$60.01
-0.511 (-0.84%)
At Close: Jun 02, 2026
Reckitt Benckiser has sales and legal risks aplenty as third-quarter results approach
10:22am, Wednesday, 02'nd Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is facing multiple challenges ahead of its third-quarter results, with Jefferies forecasting a -1% drop in like-for-like sales. Key reasons for the limp
Abbott Labs Stock Falls After Baby-Formula Ruling. Reckitt Benckiser Tumbles Too.
06:13am, Monday, 29'th Jul 2024
Shares of Abbott Laboratories and U.K.-listed Reckitt Benckiser both drop after a Missouri jury rules against the American healthcare company.
Reckitt Benckiser shares whacked by US infant formula litigation read-across
03:33am, Monday, 29'th Jul 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares tumbled 7.5% on Monday morning after a litigation decision in the US against Abbott Laboratories (NYSE:ABT) on Friday, where investors are readin
Reckitt Benckiser needs to draw line under infant formula litigation, says Barclays
08:54am, Monday, 22'nd Jul 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) half-year update on Wednesday (24 July) will see infant formula litigation remain the dominant factor, analysts at Barclays believe. One of the investme
U.K. Top 40 Quality Dividend Stocks: Summer 2024
01:25pm, Wednesday, 03'rd Jul 2024
Unfortunately, UK investors have had to suffer weak or negative capital gains in recent years to get those high yields. The good news is that the UK remains an attractive market for dividend investors
Reckitt Benckiser numbers tweaked down by leading investment bank - here's why
09:55am, Monday, 10'th Jun 2024
Barclays has issued a research note forecasting slower growth for Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) due to continued destocking of cold and flu products and a sluggish recovery in infant
Reckitt Benckiser: Attractive Price For Its Stable Of Brands (Rating Upgrade)
12:42am, Wednesday, 05'th Jun 2024
Reckitt, a consumer goods producer, has experienced a decline in share price due to concerns over its nutrition business and ongoing legal issues. Despite underwhelming business performance, Reckitt's
Reckitt Benckiser's update represents strong showing, says investment bank
10:22am, Thursday, 25'th Apr 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) reported a robust first quarter, signalling significant operational improvements under its new leadership, according to research by UBS. This comes after
Reckitt Benckiser: American bank upgrades, but remains cautious; here's why
06:43am, Tuesday, 23'rd Apr 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has been upgraded to 'hold' from 'underperform' by Jefferies, bumping its valuation up by £3 a share to £44. In a note entitled Time To Use The Slack T
U.K. Top 40 Quality Dividend Stocks: Q2 2024
01:30pm, Friday, 12'th Apr 2024
The list ranks stocks based on their market cap and dividend yield alone. What I am looking for is quality dividend stocks with long track records of progressive dividend growth, and while dividend yi
Reckitt Benckiser sees modest bounce following $7.1 billion market-cap wipeout
10:53am, Monday, 18'th Mar 2024
Reckitt Benckiser saw modest gains on Monday, following the share-price slide that erased some £5.6 billion ($7.1 billion) of market value.
Enfamil maker vows to fight $60 million baby-formula verdict
03:02pm, Friday, 15'th Mar 2024
Reckitt Beckinser Group said Friday it will seek to overturn a court ruling this week that awarded $60 million in damages to the family of a baby that died after being fed Enfamil infant formula, made
Reckitt Benckiser Group plc (RBGPF) Q4 2023 Earnings Call Transcript
06:38pm, Thursday, 29'th Feb 2024
Reckitt Benckiser Group plc (RBGPF) Q4 2023 Earnings Call Transcript
Reckitt Benckiser shares drop 11% after sales miss and Middle East 'compliance issues'
06:27am, Wednesday, 28'th Feb 2024
Shares in the Nurofen maker Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) fell 11% with the market spooked by its fourth-quarter sales miss and a £55 million revenue hit related to compliance issues
Just Eat, Reckitt Benckiser, Taylor Wimpey in focus on Wednesday
10:43am, Tuesday, 27'th Feb 2024
Any hopes that Taylor Wimpey might 'surprise on the upside' have seemingly been dashed by the CMA probe announced this week
Sign In
Buy RBGPF